graduate at Ciências Biológica from Universidade de São Paulo (1994), master's at Genetics from Universidade de São Paulo (1998) and ph.d. at Genética from Universidade de São Paulo (2002). Has experience in Genetics, focusing on Molecular Genetics and of Microorganisms, acting on the following subjects: bioinformatics, gene expression regulation, fungi, aspergillus nidulans and drug resistance. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Leishmaniasis is a pathogenic disease found throughout the world caused by protozoan parasites of the Leishmania genus. Despite the numerous problems associated with existing treatments, pharmaceutical companies continue to neglect the development of better ones. The high toxicity of current drugs combined with emerging resistance to them makes providing new therapeutic alternatives urgen…
Leishmaniasis is a pathogenic disease found throughout the world caused by protozoan parasites of the Leishmania genus. Despite the numerous problems associated with existing treatments, pharmaceutical companies continue to neglect the development of better ones. The high toxicity of current drugs combined with emerging resistance to them makes providing new therapeutic alternatives urgen…
The World Health Organization (WHO) estimates that more than one billion people suffer from neglected tropical diseases. Leishmaniasis is a widespread disease, affecting 12 million people around the world with about 1-2 million estimated new cases occurring every year. For more than 60 years, pentavalent antimonials, Sb (V) compounds, have been the first-line chemotherapy against leishman…
The leishmaniasis correspond to a set of clinical manifestations caused by different species of Leishmania, transmitted to the mammal host through the bite of infected female phlebotomines during the blood repast. This parasitic disease is labeled as neglected and therefore presents few therapeutic options for its control, which are toxic and present very difficult routes of administratio…
Parasitic diseases affect a number of people all over the world, especially in underdeveloped countries. Leishmaniasis affects around 2 million people a year, and approximately 350 million people are at risk worldwide. The current drugs used in the treatment of this parasite are not ideal, requiring less toxic and less expensive therapies. The antileishmanial compounds derived from furoxa…
Leishmaniasis, caused by more than 20 different species of protozoan Leishmania, areconsidered a serious public health problem in Brazil as well as worldwide. The limitedavailability of drugs for the treatment of this parasitic disease together with all side effectsand the emergence of resistant strains strength the importance of focus the research on thediscovery and development of new a…
(Only some records are available in English at this moment)
Leishmaniasis is a neglected disease that remains a major health problem around the word. A limited number of effective antileishmanial drugs are available for chemotherapy, and many of them are associated with high toxicity, difficult administration route and low efficacy. Therefore, there is an urgent need to develop a novel safe and effective antileishmanial drug. Previously, we report…
Leishmaniasis affects millions of people worldwide and is considered one of Neglected Tropical Diseases (NTDs) by affecting mainly the populations in developing countries. There are few drugs available for the treatment of leishmaniasis, which are toxic and often ineffective due to the emergence of resistant strains, thus the search for new compounds with leishmanicidal activity is justif…
The leishmaniasis are a group of diseases caused by the genus Leishmania. These affect 350 million people in the world in its two main forms, the cutaneous leishmaniasis and visceral leishmaniasis. After the complete sequencing of the genome of Leishmania major and the breakthrough in sequencing other species (Leishmania braziliensis, L. mexicana and L. infantum), much has been advanced r…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing research grants |
| 3 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 11 / 8 | Completed scholarships in Brazil |
| 4 / 4 | Completed scholarships abroad |
| 20 / 17 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID